Between industry news and personal experience.

What happens to the federal government's budget deficits when they have to refinance $10 trillion worth of debt at higher interest rates?

Here at the end of tax season, the CPAs are headed for the beach and the rest of us are left to lick our wounds from having to pay the taxman so much.

Believe it or not, today, I'm smiling. Why am I smiling when banks are failing and people are worried? It's for this reason.

Everybody's talking about Silicon Valley Bank, so we will too. What actually happened? Will it spread to other banks? And critically, how will it affect your financial plan? Here's a microcosm of what happened with Silicon Valley Bank.

If you are in the pharma business, and you're negotiating a compensation package, here are 3 rules to help you make sure you get what you need.

Don't wait for April 15 to come around and the accountants to show up and say "Let's see how much you owe."

We're talking about how your stock exposure works into your financial plan. Specifically, we're covering how we use stocks as a tool can help mitigate the negative impacts on your long-term plan.

No doubt about it, the economic outlook is a bit concerning, at least to me. We’re seeing real stock market volatility and with it drops in the Dow Jones, NASDAQ and S&P 500 that give most observers heartburn. But why?

While this may not be a “red” or “blue” issue, it certainly is an emotional one. The government has stepped in and waived the financial obligations of those in debt for $10,000 or less.

If you've followed Vizionary for any amount of time, you've probably heard us mention that we specialize in the pharmaceutical industry. Today, we want to answer your questions about what that means and why we chose to specialize.